Brielle, a young cancer survivor who received treatment at OHSU, received sodium thiosulfate following several chemotherapy sessions. (Courtesy of Jennifer Boesche)

Edward Neuwelt, M.D., has spent more than 20 years researching pediatric hearing loss caused by platinum-based chemotherapies. A clinical trial based on his work has found a treatment protocol that reduces hearing loss by nearly 50 percent when treating a form of pediatric liver cancer. (OHSU/Kristyna Wentz-Graff)

Verónica Vázquez, founder and manager of ICG Innovare Communication Group, with Elemento Latino creative director Marcos Aguirre. Vázquez says the early detection of cancer is important, “especially for Latinos who are less likely to seek preventive medical care.” (Courtesy of ICG)

Dr. Brian Druker, director of the OHSU Knight Cancer Institute, at the opening of the Knight Cancer Research Building at OHSU, September 7, 2018. (OHSU/Kristyna Wentz-Graff)

The Knight Cancer Institute is the only National Cancer Institute-designated Comprehensive Cancer Center between Sacramento and Seattle — an honor earned only by the nation's top cancer centers. It offers the latest treatments and technologies as well as hundreds of research studies and clinical trials. (OHSU/Christine Torres Hicks)

Shivaani Kummar, M.D., head of the division of hematology and medical oncology in the OHSU School of Medicine, and Sanjay Malhotra, Ph.D., right, are co-directors of the Knight Cancer Institute’s Center for Experimental Therapeutics. Malhotra is a professor in the departments of cell, developmental and cancer biology and oncological sciences in the OHSU School of Medicine. (OHSU/Christine Torres Hicks)

Lisa Coussens, Ph.D., Associate Director for Basic Research, OHSU Knight Cancer Institute; Chair, Department of Cell, Developmental and Cancer Biology, OHSU School of Medicine. (OHSU)